To confirm the positive correlation between KLF4 and AR signaling in prostate cancer, clinical samples from the Taylor Prostate Cancer Dataset were divided into two groups with either high or low KLF4 expression, based on a measure of the relative mRNA expression using z-scores. The gene discussed is KLF4; the disease is prostate carcinoma.